Glaxo gains, drug indices flat in early trading

GlaxoSmithKline PLC was the advancer of note among the large-cap pharmaceutical issues early Thursday, with shares climbing 2%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.